ExodusPoint Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

ExodusPoint Capital Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,796	Closed	-$491K	–	2094
2024 Q1	$491K	Sell	26,796 -368,980	-93%	-$5.86M	﹤0.01%	1144
2023 Q4	$4.86M	Sell	395,776 -370,535	-48%	-$3.48M	0.03%	350
2023 Q3	$11.5M	Buy	766,311 +714,836	+1,389%	+$14.9M	0.11%	197
2023 Q2	$1.67M	Buy	51,475 +10,463	+26%	+$382K	0.01%	885
2023 Q1	$1.6M	Buy	41,012 +15,060	+58%	+$737K	0.01%	970
2022 Q4	$1.37M	Buy	+25,952	New	+$1.26M	0.02%	809
2021 Q2	–	Sell	-6,289	Closed	-$319K	–	2919
2021 Q1	$319K	Sell	6,289 -22,108	-78%	-$1.23M	﹤0.01%	1626
2020 Q4	$1.79M	Buy	28,397 +15,368	+118%	+$953K	0.02%	585
2020 Q3	$876K	Buy	+13,029	New	+$711K	0.02%	742

Other funds holding SILK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ExodusPoint Capital Management's SILK Position: Q2 2024 in Review

ExodusPoint Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 26,796 shares — an estimated $491K sold.

ExodusPoint Capital Management first reported a position in SILK in Q3 2020 and held it in 9 quarters. The position peaked at $11.5M in Q3 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

ExodusPoint Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 26,796 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $491K.
ExodusPoint Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
ExodusPoint Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $11.5M in Q3 2023.
172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.